Inherited heart disease in children
The estimated number of children to be born with a heart defect in India is more than two lakh per year. Though about 85 to 95 percent of these children survive into adulthood due to better surgical and non-surgical techniques, they need to understand heritability and passing on of the disease to the next generation when they enter into the reproductive age group.
Israeli Univ. develops microchip to produce sperm addressing men fertility problem
The research addresses the need to find a method of producing sperm cells in the laboratory, so that it bypasses limitations such as the potential return of cancer cells to...
Roche launches PHESGO in India
May 13, 2022
RESURGENCE THE OMICRON WAY
Air pollution reduces 8 years of life expectancy in India
End inequalities to meet the target of ending AIDS
Tricuspid valve repair helps patients with ‘leaky heart valves’ to do better
The study also found that the patients who underwent tricuspid valve repair along with mitral valve surgery did not have their condition (tricuspid regurgitation) advancing to a severe stage
Six-month-old gets liver transplant in Kerala
The girl is also one of the youngest to undergo portal vein stenting Doctors from VPS Lakeshore Hospital, Kochi, have recently carried out a successful liver transplant surgery on a...
Galactosemic cataract
A 3-year-old male was brought to us by his parents with complaints of bilateral progressive lenticular opacity since early childhood. Elsewhere child was diagnosed to have a developmental cataract and...
Intuitive launches new App for surgeons using da Vinci surgical systems
The mobile app is also part of Intuitive’s digital and data support strategy as it serves as a digital portal to many parts of the Intuitive ecosystem — connecting its...
Hemex enhances Gazelle platform to test beta thalassemia
December 11, 2021
Philips launches new AI-enabled innovations in MR imaging
December 11, 2021
India approves selumetinib for neurofibro matosis type 1 children
D rugs Controller General of India (DCGI) has cleared Selumetinib 10 mg and 25mg capsules for the treatment of Pediatric patients above 3 years of age and older with neurofibromatosis...
